These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain. Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208 [TBL] [Abstract][Full Text] [Related]
7. Lack of fair play in the T cell response. Lanzavecchia A Nat Immunol; 2002 Jan; 3(1):9-10. PubMed ID: 11753400 [No Abstract] [Full Text] [Related]
8. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2. Dennig D; Yan Y; Ferguson K; O'Reilly RJ Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788 [TBL] [Abstract][Full Text] [Related]
9. T-cell alloreactivity to major histocompatibility complex peptides in context of self major histocompatibility complex. Suciu-Foca N; Xi YP; Sun YK; Liu Z Transplant Proc; 1993 Feb; 25(1 Pt 1):73-4. PubMed ID: 8438461 [No Abstract] [Full Text] [Related]
11. Class II MHC/peptide complexes on T cell antigen-presenting cells: agonistic antigen recognition inhibits subsequent antigen presentation. Mannie MD; Nardella JP; White GA; Arnold PY; Davidian DK Cell Immunol; 1998 Jun; 186(2):111-20. PubMed ID: 9665753 [TBL] [Abstract][Full Text] [Related]
12. Immunology. Inside the gearbox of the dendritic cell. Watts C Nature; 1997 Aug; 388(6644):724-5. PubMed ID: 9285579 [No Abstract] [Full Text] [Related]
13. Immunology. The cutting edge of T cell selection. Bevan MJ Science; 2007 Jun; 316(5829):1291-2. PubMed ID: 17540889 [No Abstract] [Full Text] [Related]
14. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice. Dembic Z; Hofgaard PO; Omholt H; Bogen B Scand J Immunol; 2004; 60(1-2):143-52. PubMed ID: 15238083 [TBL] [Abstract][Full Text] [Related]
15. Biophysical aspects of antigen recognition by T cells. Watts TH; McConnell HM Annu Rev Immunol; 1987; 5():461-75. PubMed ID: 3297108 [No Abstract] [Full Text] [Related]
16. Intercellular exchange of class II major histocompatibility complex/peptide complexes is a conserved process that requires activation of T cells but is constitutive in other types of antigen presenting cell. Patel DM; Mannie MD Cell Immunol; 2001 Dec; 214(2):165-72. PubMed ID: 12088415 [TBL] [Abstract][Full Text] [Related]
17. Structural principles of MHC class II antigen presentation. Nelson CA; Fremont DH Rev Immunogenet; 1999; 1(1):47-59. PubMed ID: 11256572 [TBL] [Abstract][Full Text] [Related]
18. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589 [TBL] [Abstract][Full Text] [Related]
19. Construction of MHC class I-peptide tetrameric complexes for analysis of T-cell-mediated immune responses. Samuel RV; Hanke T Methods Mol Med; 2003; 87():279-88. PubMed ID: 12958462 [No Abstract] [Full Text] [Related]
20. Description of two new major histocompatibility complex (MHC) class II DRB1 [Pan troglodytes (Patr)-DRB1] alleles. De Zorzi M; Caggiari L; Ahlenstiel G; Rehermann B; De Re V Tissue Antigens; 2008 May; 71(5):490-2. PubMed ID: 18346032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]